Molecular Genomics of Oral Submucous Fibrosis: A Narrative Review
- PMID: 40565504
- PMCID: PMC12192161
- DOI: 10.3390/genes16060612
Molecular Genomics of Oral Submucous Fibrosis: A Narrative Review
Abstract
Background: Oral Submucous Fibrosis (OSMF) is a chronic, progressive condition characterized by the fibrosis of the oral mucosa, often associated with the habitual consumption of areca nut and tobacco, leading to significant morbidity. Despite its prevalent occurrence in many parts of the world, the underlying genetic and molecular mechanisms remain poorly understood, highlighting a critical need for research into its molecular genomics. The aim of this literature review is to investigate the molecular genomics of Oral Submucous Fibrosis by analyzing the relevant literature of the past decade.
Methods: The search was conducted using MEDLINE (National Library of Medicine)-PubMed, focusing on the period 2015-2025 using the following keywords: Molecular Genomics AND Oral Submucous Fibrosis. This was followed by a manual search, and references were used to identify relevant articles.
Results: A total of 12 articles were included in our review according to our inclusion criteria, which illustrated the importance of TGF-β, Wnt inhibitory factor-1, CypA, Hsp-70 1B, Calreticulin, Lumican, Enolase 1, MMP-2, IGF-1R, XIST, Epigallocatechin-3-gallate, Von Hippel-Lindau, and MUC1 and 4.
Conclusions: Understanding the molecular pathogenesis of OSMF involves examining the molecular interactions and the roles of specific proteins. Advanced genomic technologies have opened new frontiers in the study of OSMF. As research in OSMF continues to evolve, emerging interdisciplinary approaches may provide therapeutic strategies, aiming to improve management outcomes for the patients.
Keywords: genomics; oral cancer; oral lesion; oral potentially malignant disorder; oral precancer; oral submucous fibrosis; proteomics.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Areca nut-induced oral fibrosis - Reassessing the biology of oral submucous fibrosis.J Oral Biosci. 2024 Jun;66(2):320-328. doi: 10.1016/j.job.2024.02.005. Epub 2024 Feb 22. J Oral Biosci. 2024. PMID: 38395254 Review.
-
Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.Int J Mol Sci. 2023 Jul 21;24(14):11771. doi: 10.3390/ijms241411771. Int J Mol Sci. 2023. PMID: 37511530 Free PMC article.
-
Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.J Cancer Res Ther. 2023 Apr-Jun;19(3):537-542. doi: 10.4103/jcrt.jcrt_1467_21. J Cancer Res Ther. 2023. PMID: 37470571
-
An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis.Arch Oral Biol. 2024 Jun;162:105944. doi: 10.1016/j.archoralbio.2024.105944. Epub 2024 Mar 5. Arch Oral Biol. 2024. PMID: 38492547
-
Interventions for the management of oral submucous fibrosis.Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007156. doi: 10.1002/14651858.CD007156.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2024 Feb 28;2:CD007156. doi: 10.1002/14651858.CD007156.pub3. PMID: 18843745 Updated.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous